Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis - Test2 - elhamkhani - TriplyDB

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

http://www.wikidata.org/entity/Q28198287

about

sameAs

Inflammation, stress, and diabetes Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation Mammalian Krüppel-like factors in health and diseases Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice Adipose is a conserved dosage-sensitive antiobesity gene FGF21, energy expenditure and weight loss - How much brown fat do you need?Metabolic functions of FABPs--mechanisms and therapeutic implications Adipokines as a novel link between obesity and atherosclerosis Identification and Characterization of a Small Molecule Inhibitor of Fatty Acid Binding Proteins X-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenal Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes Obesity is associated with macrophage accumulation in adipose tissue The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis Endoplasmic reticulum stress and atherosclerosis Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease Adipose overexpression of heme oxygenase-1 does not protect against high fat diet-induced insulin resistance in mice The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities Evaluation of circulating adipokines and abdominal obesity as predictors of significant myocardial ischemia using gated single-photon emission computed tomography Binding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulation Role of the fatty acid binding protein mal1 in obesity and insulin resistance The role of adipocyte XBP1 in metabolic regulation during lactation MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity Cre Recombinase Strains Used for the Study of Adipose Tissues and Adipocyte Progenitors.Adipocytokines in obesity and metabolic disease.Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis.Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma.Cell autonomous lipin 1 function is essential for development and maintenance of white and brown adipose tissue Mechanisms by which diabetes increases cardiovascular disease.Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity.A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity.Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.Fatty acid binding protein 4 deficiency protects against oxygen-induced retinopathy in mice Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages

P2860

Q24523336-67CEEC0E-C1C6-4176-B6A0-32D6D09F19D4 Q24532069-D84EE5BA-1CF8-42F3-B086-C39A65E287A7 Q24550856-B7B26D77-76E7-4387-9830-9FD012EA3E69 Q24612560-038156A7-1A46-4EC4-A230-0A4F34209BE1 Q24633352-C1E7F106-F224-47EF-90B8-9AC336A28FD6 Q24642546-32F98FCC-D1BD-4B68-94C2-39031BC04EFA Q24654087-BF9C6B2B-068B-4BF8-A677-D7D190D6A019 Q26785678-D392978D-5325-4B35-B694-F1F064084531 Q26799705-32C9F35B-CE85-42DF-88D3-6760765B4057 Q26852200-BA243E49-1630-4B0D-9C7D-938DC96FEDD4 Q27657435-4A60102B-683C-43EB-912B-A88AD569846C Q27662024-6BCA1823-D7DC-4F50-8EF5-58273E63C602 Q27703246-02804A32-9FD0-4A1F-95B8-8FB3321813E5 Q27860976-28E15976-3601-4F4B-ABB2-EB3E51BD3016 Q28074203-187F4F69-EE61-43EC-8BEB-E61BA08175FE Q28271189-FC6A47D2-9537-4C2F-BFE7-6FFD7BB4FEC5 Q28279152-EF4BBCC7-F6BC-4278-9A2A-B3C05A836D84 Q28305340-01C9AB7F-41E8-4E51-AB59-1BF09EB99526 Q28477907-E8509396-E754-4C8C-920E-B6FE04E9ECBA Q28485948-D84F73A6-31B8-4CBA-AB84-2D2F7E813746 Q28513582-270D7101-8832-411D-B31A-27D51804E70F Q28538956-C42D1D26-65F8-4FEE-8041-6CF0ED90217D Q28539602-7A1D73C4-0239-49AE-A0BF-FD8EEF88F9A9 Q28587094-F1AC2ADC-B226-449C-BFFC-27C53FD5FEAF Q28587096-C75A979D-5563-4696-8890-765CBDC20043 Q29614283-1831A3B7-069A-4559-BEFC-2374E2EBAC7F Q30241907-088585A3-E6F7-46BD-8F27-E46CB2DC72C0 Q30357655-5AA9F5AD-18E1-4ABB-AE80-B47A1957277A Q30412997-C439A864-2EA8-4724-AA11-C15FC678F41A Q30413957-CE587B24-8C8F-4BEC-A90E-14DF46964561 Q30419099-83B3487A-4A03-48B9-88EA-7BB87863A4B2 Q30441275-5A19EC76-2FB4-49D8-822E-8011036FA7E7 Q30586189-75319725-63ED-4B42-8ECA-65ECBCE525B8 Q33367128-F4358893-A212-44E7-9F80-4CA4FAEAB7F2 Q33559605-AA0CDF31-618E-47E1-BEDD-6B0D5446C41B Q33572886-2DE91A7F-901E-4F20-A073-C65347420EE9 Q33635135-214C281A-9C6A-482D-842A-08D44A2685CF Q33635141-32650D1A-7CD5-4541-BBF8-76833D8F50A2 Q33649348-680A034A-DF77-4530-AE62-0B8143756A2B Q33669547-4DDFBFEE-030A-456E-8825-7836A67743C5

P2860

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

http://www.wikidata.org/entity/Q28198287

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Lack of macrophage fatty-acid- ...... tein E against atherosclerosis

@ast

Lack of macrophage fatty-acid- ...... tein E against atherosclerosis

@en

Lack of macrophage fatty-acid- ...... tein E against atherosclerosis

@nl

type

label

Lack of macrophage fatty-acid- ...... tein E against atherosclerosis

@ast

Lack of macrophage fatty-acid- ...... tein E against atherosclerosis

@en

Lack of macrophage fatty-acid- ...... tein E against atherosclerosis

@nl

prefLabel

Lack of macrophage fatty-acid- ...... tein E against atherosclerosis

@ast

Lack of macrophage fatty-acid- ...... tein E against atherosclerosis

@en

Lack of macrophage fatty-acid- ...... tein E against atherosclerosis

@nl

P1433

Q28198287-29EF7FEC-59AF-4F3D-800F-E64133A3A968

P1476

Q28198287-83A48E5F-5807-4B2C-B51A-97A94D2581C8

P2093

Q28198287-0E586226-3E27-4167-BCF7-FA5F6034B56E

Q28198287-1BDEE8A7-C2F3-42BB-BBBB-34F27C5BD054

Q28198287-3FD9D4FC-2B0B-4B36-8037-458F4D02AE4F

Q28198287-47459D7A-EAF2-4A6F-9DC8-58903DF5E4C1

Q28198287-4FD4BFB1-BE72-46BA-97B6-34E5BF610CD7

Q28198287-631335A7-CB94-45A7-A348-7C07B2471899

Q28198287-922F149F-E1E3-44F1-A508-D07D309DC000

Q28198287-CF48082A-E6EA-45C8-AD75-EC31B83BC4BE

Q28198287-D2CCAA4A-6CE9-48F6-A1F3-B2A360D3B69F

Q28198287-D83D6CF8-6D4C-4C09-84B9-8BD879F39FE7

P2860

Q28198287-050A5359-0757-4850-B39A-5E7E0CF316E1

Q28198287-05E03184-7632-4E51-87FE-7BC3DBA954B7

Q28198287-0D12432E-4BF7-465F-ABC8-E89260E23EA0

Q28198287-141DBB85-6FC8-4063-95D0-C6B2479D22C8

Q28198287-259824FC-C1B6-4553-A5AB-F74926BA8990

Q28198287-29DB2360-973A-4931-9888-F4ECC71C5BA9

Q28198287-2B5796DE-44D0-4B50-ADB5-16ADB604F815

Q28198287-2CF6016A-7D6F-4CE6-9F74-405834D6EFD9

Q28198287-3029165E-195D-48C7-B205-3370E2966D07

Q28198287-32AA014B-2CC9-4DA4-81B9-8AE6DC37DAD8

P2888

Q28198287-D7872398-D21A-49E7-B262-27C0B3B12E02

P304

Q28198287-AAA3EBC3-A5A1-4824-A4A9-F437E5CE871D

P31

Q28198287-41961C06-28BC-46C7-8582-83620A0C50BA

P3181

Q28198287-ED6F4261-42C5-47C0-AE59-EBC5F52E6913

P356

Q28198287-1B940CAF-1898-4C53-93E4-6A21B0F2FC85

P407

Q28198287-EAFC7209-C415-4C9A-B465-7643DD1171AD

P433

Q28198287-663688A3-8D73-4C13-BCC9-64C951668BB0

P478

Q28198287-CF1D3C78-D71D-45E3-B6A8-B3788BC180EC

P577

Q28198287-C7A04416-07EF-4CD8-8979-03C5264C56C7

P5875

Q28198287-C956F0B7-EECD-4D9C-BC0A-FA1070E20F29

P698

Q28198287-160D7D36-B9AB-4655-B0FE-B289838E549A

P921

Q28198287-825D98DA-F575-4DED-82B6-C3B2A6AC3F61

Q28198287-F50027F6-696E-4906-AF63-FAAE39E730EC

Q28198287-F6C5B77A-0B74-44E0-A5D6-5C0E0F457443

P932

Q28198287-8C74A691-679E-4538-9301-AF22CEC01472

P3181

P356

P1433

Nature Medicine

P1476

Lack of macrophage fatty-acid- ...... tein E against atherosclerosis

@en

P2093

G S Hotamisligil

http://www.w3.org/2001/XMLSchema#string

J B Boord

http://www.w3.org/2001/XMLSchema#string

J Suttles

http://www.w3.org/2001/XMLSchema#string

K Maeda

http://www.w3.org/2001/XMLSchema#string

K T Uysal

http://www.w3.org/2001/XMLSchema#string

L Makowski

http://www.w3.org/2001/XMLSchema#string

M A Morgan

http://www.w3.org/2001/XMLSchema#string

M F Linton

http://www.w3.org/2001/XMLSchema#string

R A Parker

http://www.w3.org/2001/XMLSchema#string

S Fazio

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus

Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages

Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo

P2888

P304

699-705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1451179

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/89076

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11952688

http://www.w3.org/2001/XMLSchema#string

P698

11385507

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4027052

http://www.w3.org/2001/XMLSchema#string